Direct, selective, factor Xa inhibition in patients with Non-ST-Elevation acute coronary syndromes from the United States, Canada, and Japan: Results of the XaNADUACE Trial - Alexander, JH; Yang, H; Becker, RC (Thromb Haemost, 2004)
in press..